Bayer AG

BAYN

DE000BAY0017

Pharmaceuticals

Market Closed - Xetra Other stock markets 16:35:26 09/07/2025 BST			5-day change	1st Jan Change
27.33 ^EUR	+0.55%		+3.29%	+41.50%

07-09	Health Rounds: Experimental Bayer drug eases menopause-like symptoms from breast cancer therapy	RE
07-09	Bayer Wins Maiden Approval For Menopausal Hot Flashes Medication From UK Regulator	MT

BAYER : Potatoes may become a precious commodity

Published on 10/06/2025 at 12:06

This Alphavalue article, the European leader in independent research, is only available to subscribers .

Alphavalue is exclusively on MarketScreener.
To unlock the article, SUBSCRIBE!

Already a customer? Log In

Latest news about Bayer AG

Health Rounds: Experimental Bayer drug eases menopause-like symptoms from breast cancer therapy	07-09	RE
Bayer Wins Maiden Approval For Menopausal Hot Flashes Medication From UK Regulator	07-09	MT
German Equities Jump Amid EU-US Trade Deal Optimism	07-08	MT
MHRA approves elinzanetant to treat moderate to severe vasomotor symptoms caused by menopause	07-08	RE
UK Clears Bayer Medicine for Menopause-related Hot Flashes	07-08	MT
Bayer Treats First Patient in Early-stage Trial for Retinal Disorder Drug Candidate	07-08	MT
Bayer Ag and BlueRock Therapeutics LP Announces First Patient Receives Investigational Therapy in Phase 1/2a Clinical Trial of OpCT-001 for the Treatment of Primary Photoreceptor Diseases	07-08	CI
Bayer: testing OpCT-001, an experimental cell therapy	07-08	CF
Vincerx Pharma, Inc. and Vnrx, Inc Announces Termination of License Agreement with Bayer Aktiengesellschaft and Bayer Intellectual Property Gmbh	07-07	CI
BAYER AG : JP Morgan gives a Neutral rating	07-07	ZD
BAYER AG : Goldman Sachs keeps its Buy rating	07-04	ZD
General Mills changing Nature Valley labels after lawsuit's herbicide claim	07-01	RE
Bayer Announces Executive Changes for North America	07-01	CI
BAYER AG : UBS reaffirms its Neutral rating	07-01	ZD
BAYER AG : JP Morgan reiterates its Neutral rating	06-30	ZD
European shares see monthly declines as markets eye trade developments	06-30	RE
BAYER AG : Jefferies remains Neutral	06-30	ZD
Supreme Court Seeks US Government Advice on Bayer's Glyphosate Appeal	06-30	RE
Bayer Sees Request for US Solicitor General's Opinion in Weedkiller Case as 'Encouraging Step'	06-30	MT
US Supreme Court seeks Justice Department views on Bayer's Roundup appeal	06-30	RE
US Supreme Court seeks Justice Department views on Bayer's Roundup appeal	06-30	RE
Bayer says U.S. Supreme Court asks solicitor general for opinion in glyphosate case	06-30	RE
Bayer says U.S. Supreme Court asks solicitor general for opinion in glyphosate case	06-30	RE
German Stocks Rise on EU-US Trade Deal Hopes	06-27	MT
Berenberg leaves Bayer at 'Hold' – target €26	06-27	DP

Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (47.8%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (38.9%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.6%); - other (0.7%). Net sales are distributed geographically as follows: Germany (5.2%), Switzerland (1.2%), Europe/Middle East/Africa (23.6%), the United States (31.7%), North America (3.6%), China (7.7%), Asia/Pacific (9.6%), Brazil (9.3%) and Latin America (8.1%).

Employees

90,885

Sector

Pharmaceuticals

Calendar

08-06 - Q2 2025 Earnings Release

More about the company